Particle Therapy Market was valued at US$ 565 Mn. in 2021. Global Particle Therapy Market size is expected to grow at a CAGR of 8.1 % through the forecast period.
Particle Therapy Market Overview:Particle therapy is also known as radiation therapy, which uses the flow of protons, which are small particles with a positive charge, to kill tumor cells. Health care providers are increasingly offering different types of particle beam therapy to their cancer, including heavy ion therapy and proton beam therapy (PT). For the treatment of patients with bladder cancer, the non-invasive and reduced side effects of the proton therapy system are preferred. To know about the Research Methodology:-Request Free Sample Report To improve patient outcomes, particles therapy market companies are turning rewarding collaborative projects and concepts into Social Innovation solutions. Leading research and medical institutions are working together to drive innovation in radiation therapy. Technological development of cyclotron devices is one of the key ongoing strategies for the treatment of cancer patients. Particle Therapy Market COVID-19 Market: The outbreak of COVID-19 has affected all aspects of the medical device industry around the world, including particle therapy equipment. During the COVID-19 pandemic, there are significant differences in how particle beam therapy procedures are managed regionally. The particle therapy market is expected to be impacted by the temporary postponement of various selective surgery as governments and authorities seek to ensure the availability of resources for COVID-19 patients. Weekly particle beam therapy courses in 2020 decreased by 19.9% in April, 6.2% in May and 11.6% in June compared to the corresponding months in 2019. The number of attendees observed decreased relatively significantly. Various governments have issued guidelines on selective surgery to reduce the burden on the healthcare system, reduce the transmission of illness, and save on personal protective equipment (PPE). The COVID-19 is expected to increase the global cancer burden by 20%. This is due to changes in diagnostic and treatment procedures. Emergency particle beam therapy services were available at almost all centers, but the number of emergency patients visiting the centers for treatment decreased.
Particle Therapy Market Dynamics:Particle therapy has made significant technological advances in recent years. These advances have allowed manufacturers to create more effective and controlled particle beam therapy systems that are minimally invasive, have less radiation to healthy tissue, and have fewer side effects. Particle beam therapy, especially proton beam therapy, has several advantages over traditional photon therapy. These advantages are driving the growth of this market, especially in mature markets where the adoption of technologically advanced products is high. The fields of application of particle beam therapy are also expanding with advances in technologies such as point scanning and motion tracking. Spot scans significantly reduce dose exposure to surrounding healthy tissue, and real-time motion tracking allows clinicians to keep the target in the path of the beam and ensure controlled treatment. With these factors in mind, some key market players continue to focus on R & D activities to improve existing products and launch new, technologically advanced products. Increasing cancer prevalence is a major driver of the global demand for particle beam therapy (proton beam therapy and heavy ion therapy. This number is expected to increase to 24 million by 2029. Therefore, the increased prevalence of childhood cancer will drive the growth of the particle therapy market. The various benefits of the proton therapy system (high accuracy and radiation control, reduced risk of side effects, and minimal exposure of normal tissue to radiation) make it the most suitable treatment option for childhood cancer cases. This is another important factor driving market growth. In the United States, an estimated 12,690 new cancer cases will be diagnosed in 2021 in children aged 0-14 years. Particle therapy systems are expensive and require a high degree of infrastructure to install. These devices are relatively larger than photon therapy systems (including cyclotrons and synchrotrons) and require a lot of space to install. The particle therapy plant involves significant costs in terms of construction, maintenance, labor costs, and operating costs. As a result, a limited number of developing and developing countries' medical facilities can use advanced particle therapy systems. Institutionalized medical facilities due to limited medical costs are one of the main obstacles to the adoption of particle beam therapy systems, and therefore the number of particle beam therapy procedures despite high demand. More than 2,500 proton therapy rooms are needed, and 2,237 proton therapy rooms are in short supply. This huge gap between demand and existing installation bases is primarily due to high acquisition and maintenance costs. The annual cost of operating a photon therapy facility is $ 2.75 million and the annual cost of a particle beam therapy facility is $ 10.95 million. Particle therapy requires complex equipment and other services. B. Patient positioning, personalized treatment planning, and dose management software. The entire treatment cycle requires the involvement of many medical professionals, increasing the overall cost of the procedure. Particle systems are also very expensive because they have very advanced features for treating different types of cancer. In small hospitals and research institutes, especially in low- and middle-income countries, it is difficult to invest large amounts of capital in particle beam therapy centers. As a result, the adoption of these devices is limited, despite the increasing incidence of cancer. The cost per treatment with the particle system remains two to three times higher than traditional radiation therapy, and insurers often refuse to cover the cost. Healthcare facilities that purchase such expensive systems often have a third-party payer to receive a refund for the costs associated with the treatment procedures performed on these systems. It depends on health insurance companies etc. Budget-constrained healthcare facilities are also opting for regenerative systems because they cannot afford such expensive systems, limiting the production and demand for new particle therapy systems. One of the biggest challenges in particle therapy is the lack of clear visualization of the tumor and the differentiation of the tumor from normal and healthy tissue. However, because tumors can change shape on a daily basis, it is very difficult to irradiate only cancerous growth without affecting surrounding tissues. To limit this, the radiologist encloses a safety margin around the tumor. In addition, limiting the dose range of radiation therapy to minimize damage to surrounding healthy tissue limits the number of treatment cycles required to eliminate tumor cells. This is one of the main reasons for the increased cost of cancer treatment for patients receiving radiation therapy. Moreover, despite advances in imaging technology, detecting tumor progression remains a clinical challenge. Because of these challenges, oncologists prefer alternative therapeutic approaches such as chemotherapy and traditional surgical procedures. Rapid economic development and rising health care costs in many emerging markets such as China, India, Brazil and Mexico should improve access to quality health care in these countries. This is considered a positive indicator of the particle therapy market. The increased incidence of cancer in these countries has led to increased demand for a variety of particle beam therapy devices and technologies.
Particle Therapy Market Segment Analysis:Based on Type, the Particle Therapy Market is segmented into proton therapy and Heavy ion therapy. The proton therapy segment held largest market share (85.7%) in 2021. A large share of this segment is due to factors such as higher radiation dose, higher accuracy, shorter treatment times, and fewer side effects compared to traditional X-ray photon therapy. Based on the Application, the Particle Therapy Market is segmented into lung cancer, bladder cancer, brain and spinal cord tumours, and others. The brain and spinal cord segment were valued at USD 107 million in 2021 and it is expected to grow at CAGR of xx% from 2022 to 2029. The Brain and Spinal Cord Cancer (BSCT) segment is expected to occupy a large share of the international particle therapy market during the prediction interval. Based on the Services: The Particle Therapy Market is segmented into cyclotrons, synchrotrons, and synchrocyclotrons. By 2021, the Cyclotrons will have the largest share of the particle therapy market with 78.6%. The increased incidence of cancer cases is a major factor behind the growth of this segment.
Particle Therapy Market Regional Insights:The Asia Pacific region dominated the market with 35 % share in 2021. The Asia Pacific market will register the highest growth rate during the forecast period. The Asia-Pacific region is expected to offer significant growth opportunities for players in the particle therapy market due to increased health care costs and expanded initiatives to facilitate the deployment of advanced particle therapy technologies in Asia Pacific countries. I am. The North America region is expected to witness significant growth at a CAGR of 7.6% through the forecast period. The growth of the North American market is due to the early adoption of innovative medical care and the availability of more particle therapy centres. The objective of the report is to present a comprehensive analysis of the international Particle Therapy Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The reports also help in understanding the Particle Therapy Market dynamic, structure by analyzing the market segments and projecting the Particle Therapy Market size. Clear representation of competitive analysis of key players by Vehicle type, price, financial position, product portfolio, growth strategies, and regional presence in the Particle Therapy Market make the report investor’s guide.
Particle Therapy Market Scope: Inquire before buying
Global Particle Therapy Market Report Coverage Details Base Year: 2021 Forecast Period: 2022-2029 Historical Data: 2017 to 2021 Market Size in 2021: US$ 565 Mn. Forecast Period 2022 to 2029 CAGR: 8.1% Market Size in 2029: US$ 1139 Mn. Segments Covered: by Type • Proton therapy • Heavy Ion therapy by Services • Cyclotrons • Synchrotrons • Synchrocyclotrons by Application • Paediatric Cancer Lung Cancer • Bladder Cancer Brain • Spinal Cord Tumours • Others
Particle Therapy Market by Region• North America • Europe • Asia Pacific • South America • Middle East and Africa
Particle Therapy Market Key Players• IBA Worldwide • Mevion Medical Systems • Varian Medical Systems • Sumitomo Heavy Industries Ltd • Hitachi Ltd • Toshiba Medical Systems Corp. • Provision Healthcare LLC. • Danfysik A/S • Optivus Proton Therapy • ProTom International Inc • Advanced Oncology plc • Ion Beam Application SA • Advancements In the Particle Therapy • Regulatory Scenario Frequently Asked Questions: 1] What segments are covered in the Global Particle Therapy Market report? Ans. The segments covered in the Particle Therapy Market report are based on Type, Application, and Services. 2] Which region is expected to hold the highest share in the Global Particle Therapy Market? Ans. The North America region is expected to hold the highest share in the Particle Therapy Market. 3] What is the market size of the Global Particle Therapy Market by 2029? Ans. The market size of the Particle Therapy Market by 2029 is expected to reach US$ 1139 Mn. 4] What is the forecast period for the Global Particle Therapy Market? Ans. The forecast period for the Particle Therapy Market is 2022-2029. 5] What was the market size of the Global Particle Therapy Market in 2021? Ans. The market size of the Particle Therapy Market in 2021 was valued at US$ 565 Mn.
1. Global Particle Therapy Market Size: Research Methodology 2. Global Particle Therapy Market Size: Executive Summary 2.1. Market Overview and Definitions 2.1.1. Introduction to Global Particle Therapy Market Size 2.2. Summary 2.2.1. Key Findings 2.2.2. Recommendations for Investors 2.2.3. Recommendations for Market Leaders 2.2.4. Recommendations for New Market Entry 3. Global Particle Therapy Market Size: Competitive Analysis 3.1. MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2. Consolidation in the Market 3.2.1 M&A by region 3.3. Key Developments by Companies 3.4. Market Drivers 3.5. Market Restraints 3.6. Market Opportunities 3.7. Market Challenges 3.8. Market Dynamics 3.9. PORTERS Five Forces Analysis 3.10. PESTLE 3.11. Regulatory Landscape by region • North America • Europe • Asia Pacific • Middle East and Africa • South America 3.12. COVID-19 Impact 4. Global Particle Therapy Market Size Segmentation 4.1. Global Particle Therapy Market Size, by Type (2021-2029) • Proton Therapy • Heavy Ion Therapy 4.2. Global Particle Therapy Market Size, by Application (2021-2029) • Pediatric Cancer Lung Cancer • Bladder Cancer Brain • Spinal Cord Tumors • Others 4.3. Global Particle Therapy Market Size, by Services (2021-2029) • Cyclotrons • Synchrotrons • Synchrocyclotrons 5. North America Particle Therapy Market (2021-2029) 5.1. North America Particle Therapy Market Size, by Type (2021-2029) 5.1.1. Proton Therapy 5.2. Heavy Ion Therapy North America Particle Therapy Market Size, by Application (2021-2029) 5.2.1. Pediatric Cancer Lung Cancer 5.2.2. Bladder Cancer Brain 5.2.3. Spinal Cord Tumors 5.2.4. Others 5.3. North America Particle Therapy Market Size, by Services (2021-2029) 5.3.1. Cyclotrons 5.3.2. Synchrotrons 5.3.3. Synchrocyclotrons 5.4. North America Particle Therapy Market, by Country (2021-2029) • United States • Canada • Mexico 6. European Particle Therapy Market (2021-2029) 6.1. European Particle Therapy Market, by Type (2021-2029) 6.2. European Particle Therapy Market, by Application (2021-2029) 6.3. European Particle Therapy Market, by Services (2021-2029) 6.4. European Particle Therapy Market, by Country (2021-2029) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 7. Asia Pacific Particle Therapy Market (2021-2029) 7.1. Asia Pacific Particle Therapy Market, by Type (2021-2029) 7.2. Asia Pacific Particle Therapy Market, by Application (2021-2029) 7.3. Asia Pacific Particle Therapy Market, by Services (2021-2029) 7.4. Asia Pacific Particle Therapy Market, by Country (2021-2029) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 8. Middle East and Africa Particle Therapy Market (2021-2029) 8.1. Middle East and Africa Particle Therapy Market, by Type (2021-2029) 8.2. Middle East and Africa Particle Therapy Market, by Application (2021-2029) 8.3. Middle East and Africa Particle Therapy Market, by Services (2021-2029) 8.4. Middle East and Africa Particle Therapy Market, by Country (2021-2029) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 9. South America Particle Therapy Market (2021-2029) 9.1. South America Particle Therapy Market, by Type (2021-2029) 9.2. South America Particle Therapy Market, by Application (2021-2029) 9.3. South America Particle Therapy Market, by Services (2021-2029) 9.4. South America Particle Therapy Market, by Country (2021-2029) • Brazil • Argentina • Rest Of South America 10. Company Profile: Key players 10.1. Toshiba Medical Systems Corp. 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2. Provision Healthcare LLC. 10.3. Danfysik A/S 10.4. Optivus Proton Therapy 10.5. ProTom International Inc 10.6. Advanced Oncology plc 10.7. Ion Beam Application SA 10.8. Advancements In the Particle Therapy 10.9. Regulatory Scenario 10.10. IBA Worldwide 10.11. Mevion Medical Systems 10.12. Varian Medical Systems 10.13. Sumitomo Heavy Industries Ltd 10.14. Hitachi Ltd 10.15. Other